Dual Chamber Prefilled Syringes Market

Analysts at GMI Research estimates that the Dual Chamber Prefilled Syringes Market is forecast to grow at a CAGR of 7.3% from 2022-2029.

 

To have an edge over the competition by knowing the market dynamics and current trends of “Dual Chamber Prefilled Syringes Market,” request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The dual-chamber prefilled syringes market is witnessing an increase due to the prevalence of chronic and infectious diseases such as influenza, diabetes, cancer, and cardiovascular diseases, the rising geriatric population and surge in unhealthy lifestyle worldwide. For instance, as per the World Health Organization report in 2019, cardiovascular diseases are responsible for 17.9 million deaths each year, which has remained the number one cause of death globally. Cardiovascular patients widely use dual-chamber prefilled syringes for taking insulin and other lyophilized drugs as treatment. Further, increasing demand for lyophilized drugs coupled with the rapidly growing biopharmaceutical and pharmaceutical industry in the emerging economies is expected to strengthen the dual-chamber prefilled syringes market growth.

Further, rising innovation in the pharmaceutical industry with the surge in adopting the advanced method of providing drugs to avoid pain and avoid drug loss is creating new opportunities for the market in the coming years. The growing necessity of tackling potential compliance and safety issues associated with the reconstitution coupled with the rising adoption of the advanced injection method is expected to witness potential demand for this market growth. For instance, in 2019, Nipro Pharma Packaging launched CURACASE Hypodermic Needles made with hard-plastic unit packaging, strengthening the demand for dual chamber prefilled syringes market to supply complete injection systems for the pharmaceutical industry.

Impact of COVID-19 on the Dual Chamber Prefilled Syringes Market

COVID-19 pandemic has a slight impact on the global dual chamber prefilled syringes market due to restrictions imposed by the government authorities, and worldwide lockdown disrupted the necessary supply chain of pharmaceutical drugs. China is the leading provider of pharmaceutical ingredients, which stopped its manufacturing and export during the pandemic, leading to damage to the supply chain and shortage of pharmaceutical drugs.

However, the dual-chamber prefilled syringes market has shown recovery due to the gradual relaxation of lockdown restrictions in many countries and rising initiatives by the government authorities to promote in-house manufacturing worldwide by taking all the precautions and by following guidelines.

Restraint in the Dual Chamber Prefilled Syringes Market

One of the biggest factors that are likely to hinder the growth of the market is risk associated with dual chamber cross contamination during the administration of highly sensitive drugs and high cost associated for manufacturing the separable chamber prefilled syringes.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Product – Segment Analysis

Based on the product, the <1 ml products segment is anticipated to grow at a higher CAGR during the forecast period. The increasing prevalence of chronic diseases due to the rising geriatric population has propelled the demand for the <1 ml products segment. In addition to this, the introduction of innovative syringes and high convenience associated with these <1 ml syringes for the end-users will further attract more consumers towards the market. 

Material – Segment Analysis

Based on the material, the glass segment is projected to dominate the market during the forecast period. This is primarily attributed to the rising focus on the safety of the patients and demand for improving product efficiency with an affordable price range. Glass dual chamber prefilled syringes have the highest precision and available in different sizes, including microliter volumes, and have minor volume errors.

Indication- Segment Analysis

Based on the indication, the diabetes segment is projected to dominate the market during the forecast period due to rising prevalence of diabetes cases among the geriatric population and adults worldwide. Dual-chamber prefilled syringes are used for providing effective drugs to diabetic patients across the globe. For instance, according to the International Diabetes Federation, in 2019, globally, more than 463 million people have diabetes, and it is responsible for over 1.5 million deaths annually. Thus, such an increase in the prevalence of diabetes has propelled the demand for the dual-chamber prefilled syringes market growth.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Region- Segment Analysis

North America region is dominated the global dual chamber prefilled syringes market during the forecast period. North America has the highest prevalence of chronic ailments such as cancer and diabetes. The leading pharmaceutical industry and growing healthcare expenditure contribute to the demand for the dual-chamber prefilled syringes market growth. For instance, according to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) report in 2019, the global pharmaceutical industry reached US$ 1.4 Trillion. Among these, the United States has more than 40% of its contribution to the growth of the pharmaceutical industry. These factors boost the demand for the growth of the dual-chamber prefilled syringes market in North America.

Top Market Players

Various notable players operating in the market include Ypsomed AG, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Biosciences, Inc., AstraZeneca plc, AbbVie Inc., Schott Ag, Maeda Industry , Arte Corporation, Gerresheimer AG, Vetter Pharma, Nipro Corporation, Credence Med systems,and among others. 

Key Developments:

• • In 2019, Gerresheimer AG invested in manufacturing plastic systems, such as prefillable syringes, at its new plant in Skopje, North Macedonia. The plant will expand the production capacity and is likely to be in operation from the second half of 2020 in Europe. 

Segments covered in the Report:

The global dual chamber prefilled syringes market has been segmented on the basis of product, material, indication, application, and regions. Based on product, the market is segmented into <1 ml, 1 ml-2.5 ml, 2.5 ml-5.0 ml and >5.0 ml. In terms of material, the global dual chamber prefilled syringes market is divided into plastic, glass. Based on indication, the market is segmented into hemophilia, schizophrenia, diabetes, erectile dysfunction, endometriosis and others. Based on application the market is segmented into liquid/powder, and liquid/liquid. 

For detailed scope of the “Dual Chamber Prefilled Syringes Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global dual chamber prefilled syringes market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in dual chamber prefilled syringes market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global dual chamber prefilled syringes Market?
  • Which product generated maximum revenues in 2021 and identifies the most promising Product during the forecast period?
  • What are the various application areas of global dual chamber prefilled syringes marketand how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Revenues (2021)	USD Billion
Market Base Year	2021
Market Forecast Period	2022-2029
Base Year & Forecast Units	Revenues (USD Billion)
Market Segment	By Product, By Material, By Indication, By Application, andBy Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Ypsomed AG, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Biosciences, Inc., AstraZeneca plc, AbbVie Inc., Schott Ag, Maeda Industry , Arte Corporation, Gerresheimer AG, Vetter Pharma, Nipro Corporation, Credence Med systems, and among others; a total of 13 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global Dual Chamber Prefilled Syringes Market by Product

• • <1 ml
  • 1 ml-2.5 ml
  • 5 ml-5.0 ml
  • >5.0 ml

Global Dual Chamber Prefilled Syringes Market by Material

• • Glass
  • Plastic

Global Dual Chamber Prefilled Syringes Marketby Indication

• • Hemophilia
  • Schizophrenia
  • Diabetes
  • Erectile Dysfunction
  • Endometriosis
  • Others

Global Dual Chamber Prefilled Syringes Market by Region

• • North America Dual Chamber Prefilled Syringes Market (Option 1: As a part of the free 25% customization)
    • By Product
    • By Material
    • By Indication
    • US Market All-Up
    • Canada Market All-Up
  • Europe Dual Chamber Prefilled Syringes Market (Option 2: As a part of the free 25% customization)
    • By Product
    • By Material
    • By Indication
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Dual Chamber Prefilled Syringes Market (Option 3: As a part of the free 25% customization)
    • By Product
    • By Material
    • By Indication
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Dual Chamber Prefilled Syringes Market (Option 4: As a part of the free 25% customization)
    • By Product
    • By Material
    • By Indication
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region)Market All-Up

Major Players Operating in the Dual Chamber Prefilled Syringes (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Ypsomed AG
  • Otsuka America Pharmaceutical, Inc.
  • Pfizer Inc.
  • Biosciences, Inc.
  • AstraZeneca plc
  • AbbVie Inc.
  • Schott AG
  • Maeda Industry
  • Arte Corporation
  • Gerresheimer AG
  • Vetter Pharma
  • Nipro Corporation
  • Credence Medsystems